Jeremy Grantham Myriad Genetics Inc Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$20.93 - $35.1 $711,620 - $1.19 Million	-34,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$22.08 - $47.08 $750,720 - $1.6 Million	34,000 New	34,000 $973,000
Q1 2019 May 14, 2019	SELL	$26.93 - $34.7 $409,336 - $527,440	-15,200 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $146,523 - $196,326	-3,900 Reduced 20.42%	15,200 $699,000
Q1 2018 May 15, 2018	BUY	$28.83 - $41.01 $147,033 - $209,151	5,100 Added 36.43%	19,100 $564,000
Q4 2017 Feb 14, 2018	BUY	$28.45 - $37.14 $398,300 - $519,960	14,000	14,000 $481,000

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.31B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.